deCODE biostructures Expands Collaboration with InterMune
News Jun 12, 2007
deCODE biostructures, Inc. announces the initiation of a third research project with InterMune, Inc. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target.
The research fee and milestone-based research collaboration will utilize deCODE's proprietary Fragments of Life™ technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune's drug target.
A new chemical synthesis strategy to harvest the rich information found in natural products has led to the identification of novel, simpler derivatives with potential to selectively protect neurons, important for neurodegenerative diseases like Alzheimer’s disease, or to prevent the body’s immune system from rejecting organ transplants, according to a Baylor University-led study.READ MORE